9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in 9 Meters Biopharma, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- +9 vs. Q1 2021
- Shares held
- 74.4M
- −1.48M (−2.0%) vs. Q1 2021
- Total value
- $81.8M
- −$6.95M (−7.8%) vs. Q1 2021
- New holders
- 34
- 31 more added
- Sold out
- 25
- 14 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $6.43K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 6 | $22.7K |
| Q2 2023 | 34 | $2.08M |
| Q1 2023 | 39 | $4.45M |
| Q4 2022 | 42 | $3.02M |
| Q3 2022 | 74 | $10.4M |
| Q2 2022 | 88 | $15.2M |
| Q1 2022 | 101 | $45.2M |
| Q4 2021 | 104 | $76.8M |
| Q3 2021 | 105 | $94.2M |
| Q2 2021 | 99 | $81.8M |
| Q1 2021 | 90 | $88.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding 9 Meters Biopharma, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CVI Holdings, LLC | 0 | $0 | 0.00% | −2,134,460−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −1,479,963−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −564,527−100.0% | Sold out |
| Perkins Capital Management Inc | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −296,180−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −133,500−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −138,316−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −104,942−100.0% | Sold out |
| HN Saltoro Capital, LP | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −88,197−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −84,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −72,100−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −57,258−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −41,860−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −38,696−100.0% | Sold out |
| Cypress Wealth Services, LLC | 0 | $0 | 0.00% | −25,500−100.0% | Sold out |
| Sciencast Management LP | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Atlas Private Wealth Advisors | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Carroll Financial Associates, Inc. | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Abundance Wealth Counselors | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |